pmid,title,journal,year,drug,disease
39993234,Nilotinib attenuates vascular pathology in experimental cerebral malaria.,Blood advances,2025,Nilotinib,Malaria
38383841,"Network analysis-guided drug repurposing strategies targeting LPAR receptor in the interplay of COVID, Alzheimer's, and diabetes.",Scientific reports,2024,Nilotinib,Malaria
32235391,"Lapatinib, Nilotinib and Lomitapide Inhibit Haemozoin Formation in Malaria Parasites.","Molecules (Basel, Switzerland)",2020,Nilotinib,Malaria
17235418,Gateways to clinical trials.,Methods and findings in experimental and clinical pharmacology,2006,Nilotinib,Malaria
